Clinical Trial Update: Estrogen, HDL, and Coronary Heart Disease in Women [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating estrogen therapy's effect on HDL levels and coronary heart disease outcomes in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Arteriosclerosis
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: Tufts University | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 2, Phase 3 | Status: COMPLETED